The best indicator for Northrop Grumman (NOC)
We backtested 20 indicators across daily, weekly and hourly charts on real Northrop Grumman (NOC) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Northrop Grumman (NOC) over ~44.6 years — trailing buy-and-hold by 2.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Weekly | 10.8% | 0.57 | -57.1% | 71.4% | 14 | -2.0% |
| 2 | RSI Trend (>50) ✓ | Daily | 8.8% | 0.53 | -55.8% | 41.1% | 584 | -4.1% |
| 3 | EMA 50/200 Cross ✓ | Daily | 8.9% | 0.51 | -73.3% | 41.7% | 24 | -4.0% |
| 4 | RSI Trend (>50) ✓ | Weekly | 8.3% | 0.49 | -57.3% | 44.2% | 113 | -4.6% |
| 5 | Money Flow Index ✓ | Daily | 6.9% | 0.48 | -58.6% | 84.4% | 45 | -6.0% |
| 6 | Rate of Change ✓ | Daily | 7.6% | 0.48 | -57.9% | 43.8% | 698 | -5.3% |
| 7 | Williams %R ✓ | Weekly | 6.4% | 0.48 | -49.3% | 83.3% | 54 | -6.5% |
| 8 | SMA 50/200 Cross ✓ | Daily | 7.8% | 0.46 | -74.5% | 51.6% | 31 | -5.1% |
| 9 | MACD ✓ | Daily | 7.2% | 0.46 | -58.8% | 43.1% | 441 | -5.7% |
| 10 | ADX / DMI ✓ | Daily | 6.0% | 0.43 | -42.8% | 40.2% | 296 | -7.0% |
| 11 | EMA 20/50 Cross ✓ | Daily | 6.6% | 0.42 | -65.7% | 40.6% | 106 | -6.3% |
| 12 | EMA-10 Trend ✓ | Daily | 6.5% | 0.42 | -61.1% | 43.5% | 1011 | -6.5% |
| 13 | Donchian Midline ✓ | Daily | 6.3% | 0.41 | -60.4% | 41.6% | 594 | -6.7% |
| 14 | WaveTrend (8/6/4) ✓ | Weekly | 5.8% | 0.41 | -52.9% | 77.4% | 31 | -7.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Northrop Grumman (NOC), EMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.